176326-01-5
Chemical Structure
Gliadin p31-43
- CAS No.: 176326-01-5
- Formula:C71H102N18O20
- Molecular Weight:1527.68
InChIKey: VNWKTOKETHGBQD-UHFFFAOYSA-N
SMILES: O=C(N1[C@@H](CCC1)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(N)=O)C(N2[C@@H](CCC2)C(N[C@H](C(O)=O)CC3=CC=C(C=C3)O)=O)=O)=O)=O)[C@H]4N(CCC4)C([C@H](CC5=CC=CC=C5)NC([C@H]6N(CCC6)C([C@H](CCC(N)=O)NC([C@H](CCC(N)=O)NC([C@H](CCC(N)=O)NC(CNC([C@@H](N)CC(C)C)=O)=O)=O)=O)=O)=O)=O
Biological Activity: Gliadin p31-43 is an undigested gliadin peptide. Gliadin p31-43 induces an innate immune response in the intestine and interferes with endocytic trafficking. Gliadin p31-43 can be used for celiac disease research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Gliadin p31-43 | 99.75% | Gliadin p31-43 is an undigested gliadin peptide. Gliadin p31-43 induces an innate immune response in the intestine and interferes with endocytic trafficking. Gliadin p31-43 can be used for celiac disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.74
HY-P10435KEMPFPKYPVEP -
Similarity Score 0.74
HY-P11855AG3 -
Similarity Score 0.73
HY-P3933[Tyr8,Nle11] Substance P -
Similarity Score 0.73
HY-P2021BMS 180742 -
Similarity Score 0.72
HY-P1999α-Gliadin (43-49) -
Similarity Score 0.69
HY-P3587Brain-Derived Acidic Fibroblast Growth Factor (1-11) -
Similarity Score 0.68
HY-P4721Succinyl-(Pro58,D-Glu65)-Hirudin (56-65) (sulfated) -
Similarity Score 0.68
HY-103293BLys-Bradykinin tetraacetate -
Similarity Score 0.68
HY-P1636Hirudin (54-65) -
Explore the MedChemAI to find more analogs
References
- [1]. Merlin Nanayakkara, et al. P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease. Sci Rep. 2018 Jul 17;8(1):10821. [Content Brief]
- [2]. María Florencia Gómez Castro, et al. p31-43 Gliadin Peptide Forms Oligomers and Induces NLRP3 Inflammasome/Caspase 1- Dependent Mucosal Damage in Small Intestine. Front Immunol. 2019 Jan 30;10:31. [Content Brief]